RODINO-KLAPAC LOUISE (Chief Scientific Officer) received a stock award from SAREPTA THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 9/5/2025ACC: 0001193125-25-197425
Officer· Chief Scientific Officer
Since Dec 2020
+143.88K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
143.88K acquired
Non-Derivative Transactions2
Common Stock
Direct
Shares
+93.88K
Price / share
—
Trade value
—
% of position
110.8%
9/3/2025
84.74K→178.61K
Common Stock
Direct
Shares
+50K
Price / share
—
Trade value
—
% of position
28.0%
9/3/2025
178.61K→228.61K
Total
Net shares
+143.88K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/3/2025 | A · Award | +93.88K | — | — | 110.8% | 84.74K | 178.61K |
| Common Stock Direct | 9/3/2025 | A · Award | +50K | — | — | 28.0% | 178.61K | 228.61K |
| Total | +143.88K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported